Item 16. FORM 10-K SUMMARY

None.

-92-

PART IV	Signatures

RESMED INC. AND SUBSIDIARIES

SIG****NATURES

Under the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized persons below.

DATED August 16, 2021

ResMed Inc.

/s/ MICHAEL J. FARRELL
Michael J. Farrell
Chief executive officer
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE

/S/ MICHAEL J. FARRELL	Chief executive officer and director	August 16, 2021
Michael J. Farrell	(Principal Executive Officer)

/S/ BRETT A. SANDERCOCK	Chief financial officer	August 16, 2021
Brett A. Sandercock	(Principal Financial Officer and Principal Accounting Officer)

/S/ PETER C. FARRELL	Non-executive chairman	August 16, 2021
Peter C. Farrell

/S/ CAROL J. BURT	Director	August 16, 2021
Carol J. Burt

/S/ HARJIT GILL	Director	August 16, 2021
Harjit Gill

/S/ JAN De WITTE	Director	August 16, 2021
Jan De Witte

/S/ KAREN DREXLER	Director	August 16, 2021
Karen Drexler

/S/ RICHARD SULPIZIO	Director	August 16, 2021
Richard Sulpizio

/S/ RON TAYLOR	Director	August 16, 2021
Ron Taylor

-93-

Previous: Item 15. EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES

Item 16. FORM 10-K SUMMARY

Table of Contents